A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

NCT07164534 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

316

Enrollment

OTHER_GOV

Sponsor class

Conditions

Uterine Cervical Neoplasm

Interventions

DIETARY_SUPPLEMENT: Sodium-copper-chlorophyllin, a semi-synthetic derivative of chlorophyll, is made up of a mixture of sodium copper salts.

Sponsor

Tata Memorial Hospital